Portfolio news 0

Diurnal Ltd

Interim Results for the Six Months Ended 31 December 2020

Diurnal Ltd

Chronocort® distribution and marketing agreement with Consilient Health for the Nordics

C-Capture Ltd

C-Capture completes £8M funding round from IP Group, Drax, bp Ventures and the Future Fund

Aqdot

Aqdot further strengthens its Board and investor list as it scales

Tissue Regenix Group plc

Move to Electronic Reporting

Artios Pharma

Artios Pharma Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients

Aqdot

Aqdot and Elementis establish exclusive agreement to deliver proven odour capture and fragrance release benefits to anti-perspirant and deodorant formulators

Tissue Regenix Group plc

Tissue Regenix Group (AIM:TRX), the regenerative medical devices company, provides a trading update for the year ended 31 December 2020.

Centessa Pharmaceuticals plc

ApcinteX presents results from the single ascending dose study of SerpinPC in healthy volunteers and persons with severe haemophilia (Part 1 of AP-0101) at EAHAD2021

First Light Fusion Ltd

Professor Jerry Chittenden joins First Light Fusion’s Advisory Board